AXT Inc vs Bath & Body Works Inc — how do they compare? AXT Inc trades at $78.44 (market cap $4.83B), while Bath & Body Works Inc trades at $18.71 (market cap $3.81B). The key difference: AXT Inc is the larger of the two by market cap, and Bath & Body Works Inc pays a 4.24% dividend while AXT Inc pays none. Which is the better fit depends on your goals.
| AXTI | BBWI | |
|---|---|---|
Market Cap | $4.83B | $3.81B |
Sector | Technology | Consumer Cyclical |
52-Week High | $140.83 | $31.87 |
52-Week Low | $2.05 | $14.85 |
Enterprise Value | $4.50B | $7.70B |
Dividend Yield | — | 4.24% |
Signals from Pluang's Aura AI — not financial advice
AXTI trades at $77.84, up 5.46% with strong technical momentum and bullish moving average signals. The company reported record Q2 2026 results with EPS of $0.19 beating estimates by 164%, driven by surging indium phosphide demand for AI data centers. Revenue grew to $126 million in 2026 with a return to profitability at 3.23% net margin. Analyst sentiment remains positive with 73% buy ratings and a $72.50 consensus target, though valuation metrics appear elevated with P/S of 30.53.
The outlook remains constructive given AI infrastructure demand and capacity expansion plans, but risks include export restrictions, execution challenges, and rich valuations. Current price near resistance at $77 suggests potential consolidation before further upside. The company's positioning in optical connectivity for AI data centers provides growth runway, though margin sustainability and competitive pressures warrant monitoring.
BBWI trades at $19.32, down 5.11% over 24 hours, with a bearish technical signal and key support at $19. The stock shows attractive valuation metrics, including a P/E of 5.36 and P/S of 0.54, with a net income margin of 10.03% for 2025. Recent developments include expansion into Brazil and a partnership with Ulta Beauty, while Q2 2026 earnings are anticipated on August 26, 2026.
The outlook presents a value opportunity given low valuations and strategic growth initiatives, but risks include declining revenue trends, high debt levels, and negative shareholder equity. Analyst consensus is mixed with a $22.11 price target, suggesting potential upside if turnaround efforts succeed amidst competitive and execution challenges.
Trailing returns across standard periods
Latest headlines on both assets
AXT develops and manufactures high-performance compound semiconductor wafer substrates. Its products, like indium phosphide and gallium arsenide, are essential for data centers, 5G, and consumer electronics.
Read more on AXTI →Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →